Colon
Innovations in colonoscopy technology and genetic screening have made early detection more accessible. Targeted therapies, including immune checkpoint inhibitors, are providing new hope for advanced cases.
Study finds more effective treatment for head and neck cancer
A recent study explored a new way to treat certain patients with head and neck cancer. The researchers tested whether combining radiation therapy with a drug called cetuximab could improve patient outcomes compared to radiation therapy alone.
Testosterone Recovery Linked to Overall Survival in High-Risk Prostate Cancer
TUESDAY, Feb. 18, 2025 (HealthDay News) — Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients with high-risk prostate cancer receiving radiotherapy and long-term androgen deprivation therapy (ADT), according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb. 13 to 15 in San Francisco.
Support Throughout the Entire Cancer Journey
Dr. Sanft, who describes herself as a “very midwestern girl, through and through,” was raised in a mid-size town in Iowa and decided to become a doctor when she was quite young.
Cancer prevention starts in early childhood
This is Cancer Prevention Action Week (Feb. 17-23). It’s devoted to helping people make small changes in their daily lives to help prevent cancer later on. The earlier you start, the more successful you’ll be, so in Mommy Matters, five ways to start cancer prevention with your children.
US Navy veteran beats cancer with experimental treatment and reliance on faith
After facing the threat of active war, many veterans also wage battles with cancer.
AI-supported breast cancer screening—new results suggest even higher accuracy
New research results now published from Lund University’s MASAI trial are even better than the initial findings from last year: AI-supported breast screening detected 29% more cases of cancer compared with traditional screening. More invasive cancers were also clearly detected at an early stage using AI. Now the final part of the research study will focus on breast cancer missed by screening.
Computer model simplifies immune cell identification for lung cancer treatment
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.
AdventHealth plans new Palm Coast cancer center
AdventHealth is planning to open a new cancer center in Palm Coast to expand its oncology services in the region.
Key enzyme identified as potential target for cancer immunotherapy
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, is strongly induced in CD8+ T cells in solid cancer, the primary immune cells involved in combating cancer. P4HA1 causes disruptions in energy production within the cells, which leads to weaker immune cells that are less able to fight cancer and form long-lasting anti-cancer immunity, highlighting P4HA1 as a promising target for treating solid tumors.
FDA sets priority review date for Verastem Oncology’s new ovarian cancer drug – Boston Business Journal
The FDA is aiming to make a decision about the treatment before the end of June.
KU, Children’s Mercy, Saint Luke’s focus on precision medicine – Kansas City Business Journal
Using a patient’s genomics to craft a treatment plan shows great promise for cancer and rare disease patients, and these three KC-area providers are dialing up their offerings.
A new urine test could detect prostate cancer more accurately
A new urine test could detect prostate cancer more accurately
